about
Epigenetics of Aging and Alzheimer's Disease: Implications for Pharmacogenomics and Drug ResponseCaveolin-1, a stress-related oncotarget, in drug resistanceDifferential expression of miR200a-3p and miR21 in grade II-III and grade IV gliomas: evidence that miR200a-3p is regulated by O⁶-methylguanine methyltransferase and promotes temozolomide responsiveness.MiR-224 promotes the chemoresistance of human lung adenocarcinoma cells to cisplatin via regulating G₁/S transition and apoptosis by targeting p21(WAF1/CIP1).miR-21 Expression in Cancer Cells may Not Predict Resistance to Adjuvant Trastuzumab in Primary Breast Cancer.MicroRNA-7 sensitizes non-small cell lung cancer cells to paclitaxel.miR-193a-3p regulates the multi-drug resistance of bladder cancer by targeting the LOXL4 gene and the oxidative stress pathway.Correlation of long non-coding RNA expression with metastasis, drug resistance and clinical outcome in cancer.The long noncoding RNA HOTAIR contributes to cisplatin resistance of human lung adenocarcinoma cells via downregualtion of p21(WAF1/CIP1) expressionDNA damage responsive microRNAs misexpressed in human cancer modulate therapy sensitivity.MiR-1244 sensitizes the resistance of non-small cell lung cancer A549 cell to cisplatin.miR-137 regulates the constitutive androstane receptor and modulates doxorubicin sensitivity in parental and doxorubicin-resistant neuroblastoma cellsChallenges in pharmacogenetics.MicroRNA-21: a therapeutic target for reversing drug resistance in cancer.Drug resistance-related miRNAs in hepatocellular cancer.MicroRNAs and their relevance to ABC transporters.Long noncoding RNA HOTAIR involvement in cancer.HDAC inhibitor-induced drug resistance involving ATP-binding cassette transporters (Review)Molecular mechanisms and clinical implications of miRNAs in drug resistance of esophageal cancer.Phospho-ΔNp63α/microRNA network modulates epigenetic regulatory enzymes in squamous cell carcinomasThe pharmacoepigenetics of drug metabolism and transport in breast cancer: review of the literature and in silico analysis.Suppression of SPIN1-mediated PI3K-Akt pathway by miR-489 increases chemosensitivity in breast cancer.Noncoding RNA in drug resistant sarcoma.Overlapping effects of genetic variation and epigenetics on drug response: challenges of pharmacoepigenomics.Association of ATP-binding cassette transporter variants with the risk of Alzheimer's disease.Upregulation of miR-146a increases cisplatin sensitivity of the non-small cell lung cancer A549 cell line by targeting JNK-2.Integrative computational in-depth analysis of dysregulated miRNA-mRNA interactions in drug-resistant pediatric acute lymphoblastic leukemia cells: an attempt to obtain new potential gene-miRNA pathways involved in response to treatment.MicroRNA-125a-5p enhances the sensitivity of esophageal squamous cell carcinoma cells to cisplatin by suppressing the activation of the STAT3 signaling pathway.
P2860
Q26772028-44DBF345-CE4A-413F-A156-4C3E6748D3ABQ26782615-D553BDAF-F262-4C9B-AD3F-65478CE7D06CQ33911224-A027D7BA-D3C1-4152-8089-E45E497BDFF8Q33918050-73079198-52BA-4AAA-8D09-69E56635534EQ34048535-D02706F7-5DEC-4E3A-A061-4A02F868E9AFQ34293127-4332B701-8856-49C7-93B1-2FAB18495187Q34355302-8CF24C1B-C806-4912-AB7E-0CC706760FC4Q34483455-C81EA51E-EE8C-416A-89E8-E53A6A39C605Q35025421-7BF00833-C721-4459-B515-0566C32518FAQ36387641-984717F9-19C0-4C96-BA90-85FAD70B9ACAQ36790395-D3FB1B23-82EF-4884-AF70-5022650FDAC3Q37581142-8CF9441A-A108-4681-B019-E20F6D9B3257Q38103767-98AD0092-ACE8-439D-919F-1DAF36B022EEQ38122420-A84DA9DF-5C82-496F-ADAA-E7059D5F0AF7Q38185706-8564336C-87E4-45A8-8A20-5D134AD0A82EQ38197247-2F004335-9F18-4C06-9D64-50C1AC69098CQ38244306-FC461C49-8015-47B0-AFFB-248368EBD2F5Q38333926-4568DF80-FBE4-4157-92F1-DEBF31359709Q38637648-3F7108DA-65CF-49B9-97CD-0E68666D54ECQ38663683-9F9F6025-876C-474E-8FDC-73D928314458Q38937221-329B7741-785A-4D5C-9E4E-41A512B52082Q39772391-5B84B9F1-D5F6-4924-97DE-8A59AB7FD697Q41924654-80B68608-CE8A-4623-B3F0-8BE69D72BA32Q43568484-3478E76C-0DA0-4E17-B98D-607DF70B88DCQ44363685-D708B0B2-012B-40A5-A18A-67B0F654F19BQ49263988-0586F3E7-38FE-4950-A015-B71D13BEF193Q52893098-ADB91407-A84B-43F5-89EA-110E8DC67A6FQ55419057-2B694ED5-1F80-47C5-B390-DDB9A2505BED
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
miRNAs as mediators of drug resistance.
@en
type
label
miRNAs as mediators of drug resistance.
@en
prefLabel
miRNAs as mediators of drug resistance.
@en
P2860
P356
P1433
P1476
miRNAs as mediators of drug resistance
@en
P2093
Sierk Haenisch
P2860
P304
P356
10.2217/EPI.12.39
P577
2012-08-01T00:00:00Z